» Articles » PMID: 16936087

Lutein and Zeaxanthin and the Risk of Cataract: the Melbourne Visual Impairment Project

Overview
Specialty Ophthalmology
Date 2006 Aug 29
PMID 16936087
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the association of cortical, nuclear, or posterior subcapsular (PSC) cataract with dietary intake of lutein-zeaxanthin (LZ) in a population-based sample.

Methods: For the study, 3271 (83% of the eligible residents) permanent residents aged > or =40 years were recruited in 1992 to 1994 via a cluster random sampling. In 1997 to 1999, 2594 (79%) attended the follow-up examination including lens photography, a life-style questionnaire, and a food-frequency questionnaire (FFQ). Cases were those with cortical opacity > or =4/16, nuclear opacity grade > or =2.0, or PSC opacity > or =1 mm2. Logistic regression was used to calculate the odds ratios for cataract by daily LZ intake, or its quintile indicator with the lowest quintile as the baseline category, controlling for energy-adjusted fat intake and variables previously found to be associated with the cataract outcomes.

Results: Of the 2322 participants who attended the follow-up survey and completed the FFQ, 1841 (79%), 1955 (84%), and 1950 (84%) were included in the analyses of cortical, nuclear, and PSC cataract, respectively. There were 182 (9.9%), 387 (19.8%), and 177 (9.1%) cases for cortical, nuclear, and PSC cataract, respectively. Cortical and PSC cataract were not significantly associated with LZ intake. For nuclear cataract the odds ratios were 0.67 (0.46-0.96) and 0.60 (0.40-0.90) for every 1-mg increase in crude and energy-adjusted daily LZ intake, respectively. The odds ratios (95% CI) for those in the top quintile of crude LZ intake was 0.58 (0.37-0.92; P = 0.023 for trend), and it was 0.64 (0.40-1.03) for energy adjusted LZ intake (P = 0.018 for trend).

Conclusions: This study found an inverse association between high dietary LZ intake and prevalence of nuclear cataract.

Citing Articles

Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial.

Goh K, Tan E, Lim C, Tan P, Biswas S, Lew L Nutrients. 2025; 16(24.

PMID: 39770987 PMC: 11679324. DOI: 10.3390/nu16244366.


Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies.

Kulbay M, Wu K, Nirwal G, Belanger P, Tran S Biomolecules. 2024; 14(9).

PMID: 39334822 PMC: 11430732. DOI: 10.3390/biom14091055.


Review of Evidence for the Usage of Antioxidants for Eye Aging.

Choo P, Woi P, Bastion M, Omar R, Mustapha M, Din N Biomed Res Int. 2022; 2022:5810373.

PMID: 36225983 PMC: 9550496. DOI: 10.1155/2022/5810373.


Lutein plus Water Chestnut ( Roxb.) Extract Inhibits the Development of Cataracts and Induces Antioxidant Gene Expression in Lens Epithelial Cells.

Ishida H, Shibata T, Shibata S, Tanaka Y, Sasaki H, Kubo E Biomed Res Int. 2020; 2020:9204620.

PMID: 32509875 PMC: 7254081. DOI: 10.1155/2020/9204620.


Marine Bacteria versus Microalgae: Who Is the Best for Biotechnological Production of Bioactive Compounds with Antioxidant Properties and Other Biological Applications?.

Hamidi M, Safarzadeh Kozani P, Safarzadeh Kozani P, Pierre G, Michaud P, Delattre C Mar Drugs. 2020; 18(1).

PMID: 31905716 PMC: 7024282. DOI: 10.3390/md18010028.